0
0
2/15/23 at 7:54pm
Organization
Insideprecisionmedicine.com
Author
Chris Anderson
35 words
0
Comments
CD70 is highly expressed in EGFR-mutant non-small cell lung cancer (NSCLC) representing a promising new target for treatment.
You are the first to view
https://www.insideprecisionmedicine.com/topics/oncology/lung-cancer/md-anderson-researchers-id-cd70-as-new-target-in-egfr-mutant-nsclc/
Create an account
or login to join the discussion